NICE recommendations for drug coverage shown to have little impact

05/26/2004 | Financial Times (free content)

Pharmaceutical industry and related studies indicate the U.K.'s National Institute for Clinical Excellence, which recommends to the National Health Service which drugs to cover, has little impact on the introduction of new treatments. If the NICE recommendations had been adopted, according to studies by Roche, NICE and the Association of British Pharmaceutical Industry, they would have added millions to NHS drug coverage costs.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN